Skip to main content
. 2022 Winter;13(1):70–75. doi: 10.22088/cjim.13.1.70

Table 1.

The demographic characteristics and biochemical variables in PCOS-NIR, PCOS-IR, and non-PCOS groups

Variables PCOS-NIR (N = 30) PCOS-IR (N = 30) non-PCOS (N = 30) p-value
Age (years) 29.20 ± 0.91 28.27 ± 0.90 29.73 ± 0.80 0.490
Weight (kg) 69.60 ± 2.54 70.20 ± 2.38 73.02 ± 1.94 0.537
BMI (kg/m2) 28.19 ± 1.01 29.17 ± 0.91 27.88 ± 0.88 0.597
Body fat% 35.14 ± 1.15 36.10 ± 1.22 34.76 ± 1.11 0.703
FBG(mg/dl) 75.75 ± 2.55 94.10 ± 3.37 83.76 ± 2.88 0.140a
0.040b
< 0.001c
FIN(μIU/ml) 8.52 ± 0.48 20.89 ± 1.26 11.57 ± 0.74 0.046a
< 0.001b
< 0.001c
HOMA-IR 1.58 ± 0.09 4.82 ± 0.34 2.37 ± 0.15 0.039a
< 0.001b
< 0.001c
QUICKI 0.360 ± 0.004 0.306 ± 0.002 0.339 ± 0.003 < 0.001a
< 0.001b
< 0.001c
DPP4 activity
(μM/mL/min)
2.43 ± 0.08 2.63 ± 0.16 1.91 ± 0.10 0.011a
< 0.001b
0.511c
PGRN(ng/ml) 62.51 ± 13.33 63.94 ± 12.45 53.16 ± 11.41 0.259

BMI (Body mass index), FBG (Fasting blood glucose), FIN (Fasting insulin), HOMA-IR (Homeostatic model assessment of insulin resistance), QUICKI (Quantitative insulin sensitivity check index), DPP4 (Dipeptidyl peptidase-4), PGRN (Progranulin) Data are presented as means ± SE. a: PCOS-NIR vs. control, b: PCOS-IR vs. control, c: PCOS-NIR vs. PCOS-IR